| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Divisions of Oncology [J. L. K., D. J. Y., G. M. B.] and Neurology [J. L. R., G. I. T.], The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4318
Neuroblastomas are histopathologically heterogeneous, ranging from immature malignant tumors to benign ganglioneuromas. The amount of Schwann cell stroma greatly increases with neuroblastoma differentiation, and these Schwann cells appear to be normal cells that infiltrate the tumor. To determine whether Schwann cells influence neuroblast differentiation, four human neuroblastoma cell lines were cultured in the presence or absence of human Schwann cell-conditioned medium for 7 days. Neuroblastoma cell survival, as determined by a colorimetric assay, more than doubled in three of the four neuroblastoma cell lines in the Schwann cell-conditioned medium. There was a corresponding reduction in apoptosis as measured by a nick-end labeling assay, with little change in mitotic rate. Schwann cell-conditioned medium induced extensive neurite outgrowth in all of the neuroblastoma cell lines, and these processes contained mature neurofilament in three of the cell lines. These results indicate that Schwann cells produce soluble substances capable of supporting survival and differentiation in neuroblastoma cell lines. This may represent a biological mechanism responsible for neuronal differentiation in stroma-rich neuroblastomas.
1 This work was supported by NIH Grants T-32 HL07150 (to J. L. K.), NS-34514 (to G. M. B.), and NS-36061 and NS-08075 (to J. L. R.); Joseph Stokes, Jr. Research Funds (to G. I. T.); and the Audrey E. Evans Endowed Chair (G. M. B.).
2 To whom requests for reprints should be addressed, at The Children's Hospital of Philadelphia, Division of Oncology, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104-4318. Phone: (215) 590-4855; Fax: (215) 590-3770.
3 Current address: Division of Pediatric Oncology, College of Physicians & Surgeons of Columbia University, New York, NY 10032.
Received 8/12/98. Accepted 9/ 1/98.
This article has been cited by other articles:
![]() |
R. Ulrich, A. C. Stan, A. Koch, and A. Beineke Expression of Brain-derived Neurotrophic Factor and Tropomyosin-related Kinase-B in a Bovine Jejunal Nodular Ganglioneuroblastoma Vet. Pathol., May 1, 2008; 45(3): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Peddinti, R. Zeine, D. Luca, R. Seshadri, A. Chlenski, K. Cole, B. Pawel, H. R. Salwen, J. M. Maris, and S. L. Cohn Prominent Microvascular Proliferation in Clinically Aggressive Neuroblastoma Clin. Cancer Res., June 15, 2007; 13(12): 3499 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, Y. Tian, A. Chlenski, Q. Yang, P. Zage, H. R. Salwen, S. E. Crawford, and S. L. Cohn Cross-Talk between Schwann Cells and Neuroblasts Influences the Biology of Neuroblastoma Xenografts Am. J. Pathol., March 1, 2005; 166(3): 891 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chlenski, S. Liu, S. E. Crawford, O. V. Volpert, G. H. DeVries, A. Evangelista, Q. Yang, H. R. Salwen, R. Farrer, J. Bray, et al. SPARC Is a Key Schwannian-derived Inhibitor Controlling Neuroblastoma Tumor Angiogenesis Cancer Res., December 15, 2002; 62(24): 7357 - 7363. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Crawford, V. Stellmach, M. Ranalli, X. Huang, L. Huang, O. Volpert, G. H. De Vries, L. P. Abramson, and N. Bouck Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity J. Cell Sci., March 14, 2002; 114(24): 4421 - 4428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Eggert, M. A. Grotzer, N. Ikegaki, X.-g. Liu, A. E. Evans, and G. M. Brodeur Expression of the Neurotrophin Receptor TrkA Down-Regulates Expression and Function of Angiogenic Stimulators in SH-SY5Y Neuroblastoma Cells Cancer Res., March 1, 2002; 62(6): 1802 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Huang, J. L. Rutkowski, G. M. Brodeur, P. M. Chou, J. L. Kwiatkowski, A. Babbo, and S. L. Cohn Schwann Cell-conditioned Medium Inhibits Angiogenesis Cancer Res., November 1, 2000; 60(21): 5966 - 5971. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |